‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – National
Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by American drugmaker Eli Lilly under the brand...
Tag : Alzheimers
Could a gene therapy treat the vast majority of Alzheimer’s?
Alzheimer’s disease, the most common form of dementia, has beaten back potential treatments for decades. Past research suggested it was a complicated, multifactorial disease in...
Single protein could dramatically alter trajectory of Alzheimer’s disease
A single gene mutation protects against Alzheimer’s disease in people destined to get the disease very young — and now we know why. The gene...